# Netherlands Telemedicine Market Size, Share & Forecast, By Service Type, Care Setting & Technology, 2026-2031 --- ## Market Overview # CHAPTER 1 - Market Overview The Netherlands Telemedicine Market operates through reimbursed teleconsultations, remote diagnostics, digital mental-health treatment and device-enabled monitoring delivered by hospitals, general practices and specialized virtual-care providers. Demand is underpinned by a population of 18.0 million in 2025, including 3.75 million people aged 65 or older, increasing the need for lower-cost chronic-care capacity outside hospitals. Commercial activity is concentrated in the Randstad, where Amsterdam, Rotterdam, The Hague and Utrecht combine university medical centers, major insurers, digital-health talent and dense provider networks. The region is estimated to account for 58% of 2025 telemedicine revenue, while Dutch hospitals and ambulatory providers together represented more than EUR 65 billion of healthcare expenditure, creating a large addressable procurement base. Reimbursement is a decisive market-access factor. The Dutch Healthcare Authority permits a dedicated telemonitoring add-on for specialist care, with a maximum tariff of EUR 194.92 in 2026 and no separate contract requirement. This shifts telemedicine from discretionary innovation budgets toward recurring clinical revenue, but it also raises evidence, workflow and coding requirements for vendors seeking scalable adoption. The strategic direction is hybrid care rather than digital-only substitution. The Integral Care Agreement targets approximately 70% hybrid-capable care provision and 50% of healthcare users receiving hybrid care by end-2026. In parallel, the European Health Data Space entered into force in March 2025, creating a multi-year interoperability transition that favors platforms able to exchange structured records securely. ## KPIs at a Glance * Market Value: USD 2,500 million (2025) * Dominant Region: Randstad (2025) * Dominant Segment: Remote Patient Monitoring (fastest growing, 2026-2031) * Total Number of Players: 80 ## Future Outlook The Netherlands Telemedicine Market is projected to expand from USD 2,500 million in 2025 to USD 6,479 million by 2031. The 2020-2025 historical CAGR of 15.6% reflected pandemic acceleration, normalization of digital contact and increasing hospital investment in remote-care workflows. Forecast growth is expected to strengthen to a 17.2% CAGR during 2026-2031 as reimbursed telemonitoring, hospital-at-home pathways and interoperable patient communication move into routine care. Remote patient monitoring will capture the largest incremental profit pool because it combines recurring software fees, connected-device revenues, clinical monitoring services and measurable reductions in avoidable visits. Growth will be uneven across delivery models. Integrated platforms linked to electronic medical records, insurer contracts and clinical protocols are expected to outperform stand-alone video tools. By 2031, connected monitoring and AI-supported triage should represent a materially larger share of sector value, while basic teleconsultation becomes a lower-margin feature within broader care pathways. The main execution constraint will be workforce and workflow redesign rather than connectivity, given the Netherlands' strong broadband infrastructure. Vendors that demonstrate clinical outcomes, privacy compliance and integration speed will be positioned to capture national-scale contracts from hospital groups, primary-care networks and insurers. --- | | | | --- | --- | | **17.2%** Forecast CAGR | **$6,479 Mn** 2031 Projection | --- | | | | | | --- | --- | --- | --- | | Base Year **2025** | Historical Period **2020-2025** | Forecast Period **2026-2031** | Historical CAGR **15.6%** | --- --- ## Scope of the Report # CHAPTER 2 - Scope of the Market * **Geographic Coverage:** Netherlands * **Historical Period:** 2020-2025 * **Base Year:** 2025 * **Forecast Period:** 2026-2031 * **Market Segments Covered:** 7 primary segmentation dimensions (Service Type, Care Setting, End User, Clinical Specialty, Delivery Channel, Technology, Geography) * **Companies Covered:** Top 10 key players profiled * **Currency & Units:** USD, values expressed in USD Mn/Bn ### Segmentation Data Tree * Service Type + Teleconsultation Services - Scheduled video consultations - Asynchronous e-consultations - Second medical opinions + Remote Patient Monitoring - Vital-sign monitoring - Post-discharge monitoring - Medication adherence monitoring + Tele-diagnostics - Teledermatology - Telecardiology - Teleradiology + Digital Therapeutics and Coaching - Mental-health interventions - Chronic-care coaching - Rehabilitation programs * Care Setting + Hospitals and University Medical Centers - Outpatient virtual clinics - Virtual wards - Post-acute pathways + General Practice and Primary Care - GP e-consultations - Primary-care diagnostics - Community specialist access + Mental Health and Rehabilitation - Specialist mental healthcare - Primary mental-health support - Remote rehabilitation + Home and Long-Term Care - District nursing - Elderly home care - Disability support * End User + Healthcare Providers - Hospitals - GP cooperatives - Independent clinics + Health Insurers - National insurers - Regional purchasing alliances - Supplementary insurers + Patients and Caregivers - Chronic-care patients - Older adults - Informal caregivers + Employers and Public Health Bodies - Occupational health providers - Municipal health services - Population-health programs * Clinical Specialty + Mental Health - Anxiety and depression - Addiction care - Behavioral coaching + Cardiology and Chronic Care - Heart failure - Hypertension - Cardiac rhythm monitoring + Dermatology - Primary lesion assessment - Chronic skin conditions - Specialist referrals + Pulmonology and Diabetes - COPD - Asthma - Diabetes management * Delivery Channel + Mobile Applications - Patient monitoring apps - Messaging apps - Therapy apps + Web Portals - Provider dashboards - Patient portals - Insurer portals + Integrated EHR Platforms - Hospital EHR modules - GP information-system modules - FHIR-connected services + Contact Centers and Video Hubs - Nurse triage centers - Virtual specialist desks - 24-hour support hubs * Technology + Cloud Software - Software-as-a-service platforms - Workflow orchestration - Clinical content libraries + Connected Medical Devices - Blood-pressure monitors - Pulse oximeters - Wearable sensors + AI and Analytics - Risk stratification - Automated triage - Clinical decision support + Interoperability APIs - FHIR interfaces - Identity and consent services - Health-data exchange connectors * Geography + Randstad - Amsterdam cluster - Rotterdam-The Hague cluster - Utrecht cluster + North Netherlands - Groningen - Friesland - Drenthe + East Netherlands - Gelderland - Overijssel - Flevoland + South Netherlands - North Brabant - Limburg - Zeeland --- --- ## Market Trajectory # Netherlands Telemedicine Market Size, Share & Forecast, By Service Type, Care Setting & Technology, 2026-2031 **Geography:** Netherlands | **Historical Period:** 2020-2025 | **Forecast Period:** 2026-2031 The Netherlands Telemedicine Market reached USD 2,500 million in 2025, supported by rapid normalization of video-enabled care, insurer-backed reimbursement and expansion of remote monitoring across chronic disease pathways. With around 80% of GPs and hospital physicians using video calls in 2025, telemedicine is moving from a point solution toward an integrated care-delivery layer. ## Report Metadata Summary | Base Year | CAGR for Past 5 Years | Historical Period | Forecast Period | Forecast CAGR | | --- | --- | --- | --- | --- | | 2025 | 15.6% | 2020-2025 | 2026-2031 | 17.2% | --- # CHAPTER 3 - Market Size, Growth Forecast and Trends This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. | Year | Historical and Projected Market Size (USD Mn) | | --- | --- | | 2020 | 1,210 | | 2021 | 1,430 | | 2022 | 1,660 | | 2023 | 1,910 | | 2024 | 2,190 | | 2025 | 2,500 | | 2026F | 2,930 | | 2027F | 3,434 | | 2028F | 4,025 | | 2029F | 4,717 | | 2030F | 5,528 | | 2031F | 6,479 | | Year | YoY Growth Rate (%) | | --- | --- | | 2021 | 18.2% | | 2022 | 16.1% | | 2023 | 15.1% | | 2024 | 14.7% | | 2025 | 14.2% | | 2026F | 17.2% | | 2027F | 17.2% | | 2028F | 17.2% | | 2029F | 17.2% | | 2030F | 17.2% | | 2031F | 17.2% | | Year | Market Value Growth (%) | Telemedicine Engagement Volume Growth (%) | | --- | --- | --- | | 2020 | - | - | | 2021 | 18.2% | 19.1% | | 2022 | 16.1% | 15.1% | | 2023 | 15.1% | 13.9% | | 2024 | 14.7% | 12.9% | | 2025 | 14.2% | 13.4% | | 2026F | 17.2% | 13.5% | | 2027F | 17.2% | 12.9% | | 2028F | 17.2% | 13.2% | | 2029F | 17.2% | 13.2% | | 2030F | 17.2% | 13.0% | ### Historical Market Performance (2020-2025) Historical growth peaked at 18.2% in 2021 as providers rapidly institutionalized virtual consultations and remote follow-up. Growth moderated to 14.2% by 2025, but the deceleration reflected normalization rather than weakening demand. The market's structural inflection occurred as provider video-call usage increased from around 60% in 2024 to about 80% in 2025, while mental-health self-help and patient-portal use also rose. Revenue concentration shifted from stand-alone video solutions toward integrated monitoring, diagnostics and disease-specific pathways. ### Forecast Market Outlook (2026-2031) The forecast assumes 17.2% annual growth as reimbursement, hybrid-care targets and hospital-at-home programs expand recurring revenue. Value growth is expected to exceed engagement-volume growth by roughly 3-4 percentage points annually because remote monitoring adds device, analytics and clinical-service layers to each patient pathway. The terminal 2031 value reflects higher penetration in cardiology, pulmonology, mental health and post-discharge care, while EHDS implementation strengthens demand for interoperable platforms. --- --- ## Market Breakdown # CHAPTER 4 - Market Breakdown The Netherlands Telemedicine Market is transitioning from episodic virtual consultations to longitudinal, data-enabled care. For CEOs and investors, growth quality increasingly depends on recurring monitored-patient revenue, provider workflow integration and reimbursement capture. | Year | Market Size (USD Mn) | YoY Growth (%) | Telemedicine Patient Engagements (Mn) | Providers Offering Video or Remote Care (%) | Revenue per Engagement (USD) | Period | | --- | --- | --- | --- | --- | --- | --- | | 2020 | 1,210 | - | 8.9 | 38% | 136 | Historical | | 2021 | 1,430 | 18.2% | 10.6 | 55% | 135 | Historical | | 2022 | 1,660 | 16.1% | 12.2 | 63% | 136 | Historical | | 2023 | 1,910 | 15.1% | 13.9 | 68% | 137 | Historical | | 2024 | 2,190 | 14.7% | 15.7 | 72% | 139 | Historical | | 2025 | 2,500 | 14.2% | 17.8 | 80% | 140 | Base Year | | 2026 | 2,930 | 17.2% | 20.2 | 84% | 145 | Forecast and Latest Operating KPIs | | 2027 | 3,434 | 17.2% | 22.8 | 87% | 151 | Forecast and Industry Outlook | | 2028 | 4,025 | 17.2% | 25.8 | 89% | 156 | Forecast and Industry Outlook | | 2029 | 4,717 | 17.2% | 29.2 | 91% | 162 | Forecast and Industry Outlook | | 2030 | 5,528 | 17.2% | 33.0 | 93% | 168 | Forecast and Industry Outlook | | 2031 | 6,479 | 17.2% | 37.3 | 95% | 174 | Forecast and Industry Outlook | **KPI 1, Telemedicine Patient Engagements:** **17.8 million, 2025, Netherlands**. Engagement scale determines platform utilization, device demand and clinical-service staffing. Ksyos alone reported approximately 250,000 patients in its latest year, demonstrating that specialized providers can reach national volume through GP networks. **KPI 2, Providers Offering Video or Remote Care:** **80%, 2025, Netherlands**. High provider adoption reduces customer education costs and shifts competition toward integration and outcomes. The share using video calls rose from around 60% in 2024 to around 80% in 2025. **KPI 3, Revenue per Engagement:** **USD 140, 2025, Netherlands**. Revenue per engagement rises when platforms combine consultation, monitoring, connected devices and pathway management. The 2026 Dutch telemonitoring add-on tariff is capped at EUR 194.92, providing a reimbursement anchor for higher-value monitored episodes. --- --- ## Market Segmentation # CHAPTER 5 - Market Segmentation Framework Comprehensive analysis across key dimensions providing insights into market structure, consumer preferences, and distribution patterns. | | | | | --- | --- | --- | | **No of Segments:** 7 | **Dominant Segment:** Service Type | **Fastest Growing Segment:** Technology | ### Segmentation Framework | Priority | Level-1 Segment / Taxonomy Dimension | Level-2 Sub-Segments | | --- | --- | --- | | 1 | Service Type | Teleconsultation Services; Remote Patient Monitoring; Tele-diagnostics; Digital Therapeutics and Coaching | | 2 | Care Setting | Hospitals and University Medical Centers; General Practice and Primary Care; Mental Health and Rehabilitation; Home and Long-Term Care | | 3 | End User | Healthcare Providers; Health Insurers; Patients and Caregivers; Employers and Public Health Bodies | | 4 | Clinical Specialty | Mental Health; Cardiology and Chronic Care; Dermatology; Pulmonology and Diabetes | | 5 | Delivery Channel | Mobile Applications; Web Portals; Integrated EHR Platforms; Contact Centers and Video Hubs | | 6 | Technology | Cloud Software; Connected Medical Devices; AI and Analytics; Interoperability APIs | | 7 | Geography | Randstad; North Netherlands; East Netherlands; South Netherlands | ### Key Segmentation Takeaways Comprehensive analysis across all extracted segmentation dimensions providing insights into market structure, consumer preferences, and distribution patterns. **Service Type** - Service Type is the dominant dimension because procurement budgets are allocated around clinical workflows rather than isolated technologies. Remote Patient Monitoring is the largest incremental revenue pool, combining software subscriptions, device bundles, nurse monitoring and pathway redesign. Teleconsultation remains the broadest-volume service, but pricing pressure is increasing as messaging and video become standard features inside larger platforms. **Technology** - Technology is the fastest-growing dimension because hospitals increasingly require cloud deployment, device connectivity, AI-supported triage and standards-based integration. AI and Analytics is the fastest-growing sub-segment, supported by clinical workforce constraints and rising data volumes. Interoperability APIs also gain strategic value as EHDS milestones require structured exchange of patient summaries, prescriptions, images, laboratory results and discharge information. --- --- ## Regional Analysis # CHAPTER 6 - Regional Analysis The Netherlands ranks fourth among selected Western and Northern European telemedicine peers by 2025 market size, behind Germany, the United Kingdom and France, but ahead of Belgium and Denmark. Its position reflects high healthcare spending, advanced connectivity and strong hybrid-care policy support, although its smaller population limits absolute scale. ### KPI Summary * Focus Country Ranking: **4th** * Focus Country Market Size: **USD 2.5 Bn (2025)** * Focus Country CAGR: **17.2% (2026-2031)** | Country | Market Size (USD Bn, 2025) | CAGR (%, 2026-2031) | Health Spending per Capita (USD PPP, 2024) | Practising Doctors per 1,000 Population | | --- | --- | --- | --- | --- | | Germany | 9.0 | 17.8% | 9,365 | 4.7 | | United Kingdom | 7.6 | 18.4% | 6,747 | 3.4 | | France | 6.0 | 17.5% | 7,367 | 3.9 | | Netherlands | 2.5 | 17.2% | 8,436 | 3.9 | | Belgium | 1.4 | 16.9% | 7,750 | 3.4 | | Denmark | 0.8 | 12.9% | 7,071 | 4.5 | ### Market Position The Netherlands ranks fourth with USD 2.5 billion in 2025, supported by USD 8,436 health spending per capita and a highly digitized provider base. ### Growth Advantage At 17.2%, Dutch forecast growth is near France and Germany, above Belgium and Denmark, but below the United Kingdom's faster virtual-care expansion. ### Competitive Strengths Strengths include 98.3% very-high-capacity network coverage, 100% 5G household coverage and a 70% hybrid-capable care target for end-2026. Comprehensive analysis of key factors shaping the market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. --- --- ## Growth Drivers # CHAPTER 7 - Growth Drivers, Challenges & Opportunities Comprehensive analysis of key factors shaping the Netherlands Telemedicine Market, including growth catalysts, operational challenges, and emerging opportunities across production, distribution, and consumer segments. ## Growth Drivers ### Institutional Shift Toward Hybrid Care National agreements target **70% hybrid-capable care provision (2026, Netherlands)**, moving digital pathways into mainstream operating models. * Hybrid-care targets create multi-year procurement demand for workflow, communication and monitoring platforms because providers must redesign patient journeys rather than simply add video visits. **50% of healthcare users targeted for hybrid care (2026, Netherlands)**. * Reimbursement supports recurring revenue: specialist telemonitoring can be billed through a dedicated add-on with a **EUR 194.92 maximum tariff (2026, Netherlands)**, improving vendor and provider business cases. * Medical specialists and nurses expanded digital service provision across care processes by an average **21% (2025, Netherlands)**, enlarging the addressable implementation base for enterprise platforms. ### Ageing and Chronic-Care Capacity Pressure The population aged 65 or older reaches **3.75 million (2025, Netherlands)**, increasing demand for home-based monitoring and remote support. * The 65-plus population is projected to rise to **4.17 million (2030, Netherlands)**, expanding the pool requiring cardiology, diabetes, respiratory and medication-adherence services. * Long-term care spending increased **7.6% (2025, Netherlands)**, strengthening the financial incentive to substitute selected in-person contacts with scalable monitored care. * Health expenditure reached **10.2% of GDP (2025, Netherlands)**, making cost avoidance and productivity evidence central to purchasing decisions by insurers and provider groups. ### High Digital Readiness and Provider Adoption Video-call use reached around **80% of GPs and hospital doctors (2025, Netherlands)**, reducing behavioral barriers to telemedicine adoption. * Very-high-capacity networks covered **98.3% of households (2023, Netherlands)**, supporting reliable video, data transmission and home-monitoring services nationally. * At least one 5G network covered **100% of households (2023, Netherlands)**, enabling mobile monitoring and faster deployment beyond hospital campuses. * Dutch citizens reporting that digitalized services make life easier reached **84% (2025, Netherlands)**, supporting patient acceptance when services remain simple and integrated. --- ## Market Challenges ### Persistent Digital Inclusion Gap Older and lower-education groups use digital care **20%-45% less often (2025, Netherlands)**, limiting universal adoption and creating support costs. * Providers must retain non-digital alternatives and assisted onboarding, raising service-delivery costs and reducing the margin advantage of digital channels for vulnerable cohorts. **3.75 million residents aged 65-plus (2025, Netherlands)**. * Low digital confidence can reduce adherence to monitoring protocols, weakening clinical outcomes and insurer willingness to fund large-scale deployments. **Gap unchanged since 2021 (2025 monitor, Netherlands)**. * Vendors serving elderly and long-term-care users need device simplicity, multilingual support and caregiver access, increasing product complexity. **29.6% of health spending allocated to long-term care (2025, Netherlands)**. ### Fragmented Interoperability and Workflow Integration E-health service delivery remains **fragmented (2026, Netherlands)**, slowing procurement and increasing implementation costs across provider networks. * Hospital, GP, insurer and long-term-care systems use different workflows, so integration can consume more resources than the telemedicine application itself. **EUR 5.25 billion national digital roadmap (2025, Netherlands)**. * EHDS obligations begin in stages from **2029 and 2031 (EU)**, requiring vendors to invest early in structured data exchange, consent and interoperability. * Platforms lacking FHIR interfaces or EHR partnerships face slower deployment and weaker renewal economics. **Second priority data group operational by March 2031 (EU)**. ### Uncertain Productivity Realization **45% of healthcare employees (pre-2024, Netherlands)** considered workload too high, yet digital care does not automatically reduce it. * GPs often report that digital care adds workload except for telemonitoring, so vendors must demonstrate task substitution rather than create parallel inboxes. **70% hybrid-care target (2026, Netherlands)**. * Care users and providers are only neutral to moderately positive about cost reduction, increasing pressure for outcome-linked contracting. **USD 8,436 health spending per capita (2024, Netherlands)**. * ICT-specialist shortages slow deployment and support capacity, particularly for smaller providers. **59 edge nodes and 32 unicorns (2024, Netherlands)** coexist with a structural talent gap. --- ## Market Opportunities ### Scaled Remote Monitoring for Chronic Disease Remote monitoring can monetize a growing pool of **4.17 million older residents (2030, Netherlands)** through recurring pathway contracts. * Monetizable models include per-patient subscriptions, device leasing and nurse-monitoring services, supported by a **EUR 194.92 telemonitoring tariff cap (2026, Netherlands)**. * Hospitals, insurers, device makers and virtual-care operators benefit by reducing avoidable visits while creating recurring revenue across cardiology, COPD and diabetes pathways. **USD 55.4 billion curative-care spend equivalent (2025, Netherlands)**. * Scale requires standard clinical protocols, EHR integration and centralized monitoring teams; Ksyos demonstrates national reach through **7,000 connected GPs (2026, Netherlands)**. ### Interoperability-as-a-Service EHDS creates a compliance-led opportunity as **priority health-data exchange begins in 2029 (EU)** and broadens in 2031. * Vendors can monetize APIs, consent management, identity services and data-quality tooling as hospitals modernize fragmented interfaces. **EUR 11 billion expected EU savings over a decade (EHDS estimate)**. * Platform providers, EHR vendors and system integrators benefit because interoperability becomes a purchasing requirement rather than an optional feature. **20%-30% projected digital-health sector expansion (EU estimate)**. * Adoption requires common specifications and governance, with key implementing acts due by **March 2027 (EU)**, giving suppliers a defined preparation window. ### AI-Supported Clinical Triage and Automation Provider use of AI is increasing while digital services expanded **21% among specialists and nurses (2025, Netherlands)**, creating automation demand. * Revenue models include AI triage modules, risk-scoring subscriptions and automated documentation, improving revenue per clinician without relying solely on consultation volume. **80% video-call adoption (2025, Netherlands)**. * Hospitals and virtual-care providers benefit from prioritizing high-risk patients and reducing routine review time across large monitoring panels. **850 Ksyos patients served daily (2026, Netherlands)**. * Materialization requires clinical validation, human oversight and compliant data governance because AI affects diagnosis and prioritization. **EHDS entered into force 26 March 2025 (EU)**. --- --- ## Competitive Landscape # CHAPTER 8 - Competitive Landscape Overview The market is moderately concentrated around national-scale care platforms, hospital communication services and remote-monitoring specialists, with integration capability, reimbursement access, clinical evidence and installed provider networks forming the primary entry barriers. * **Key players:** 10 * **New Entrants (last 5 yrs):** 14 ### Company Profiles (Top 10 Players) | Company Name | Market Share | Headquarters | Founding Year | Core Market Focus | | --- | --- | --- | --- | --- | | Philips Healthcare | - | Amsterdam, Netherlands | 1891 | Enterprise telehealth, connected care and patient monitoring | | Ksyos | - | Amsterdam, Netherlands | 2001 | Digitally mediated specialist care and tele-diagnostics | | Luscii | - | Utrecht, Netherlands | 2018 | Remote patient monitoring and care-at-home pathways | | BeterDichtbij | - | Utrecht, Netherlands | - | Secure patient-provider messaging and video communication | | Minddistrict | - | Amsterdam, Netherlands | 2008 | Digital mental-health treatment and blended care | | Sananet | - | Sittard-Geleen, Netherlands | - | Chronic-care coaching and remote monitoring | | Karify | - | Utrecht, Netherlands | - | Secure e-health workspaces and digital treatment | | Medicinfo | - | Tilburg, Netherlands | - | Digital triage, teleconsultation and medical contact centers | | MiBida | - | Netherlands | - | Remote patient management and virtual care pathways | | Tunstall Healthcare | - | Whitley, United Kingdom | 1957 | Telecare, connected health and remote support services | The report provides detailed cross-comparison of key players across 4 performance parameters to identify competitive strengths and weaknesses. ### Top 4 Cross-Comparison KPIs * Monitored Patient Scale * EHR Integration Coverage * Recurring Revenue Growth * Gross Margin ### Analysis Covered * **Market Share Analysis:** Estimates provider positioning across service categories and clinical pathways. * **Cross Comparison Matrix:** Benchmarks operational reach, integration depth, growth and profitability performance. * **SWOT Analysis:** Assesses platform strengths, execution gaps, market risks and opportunities. * **Pricing Strategy Analysis:** Compares subscription, per-patient, reimbursed-service and enterprise contract models. * **Company Profiles:** Reviews ownership, products, partnerships, clinical focus and geographic reach. --- --- ## Key Stakeholders # CHAPTER 10 - Key Target Audience Key stakeholders who can leverage from this market analysis for investment, strategy, and operational planning. * **Investors:** CAGR, recurring revenue, clinical evidence, reimbursement risk, exits * **Corporates:** integration cost, patient scale, renewals, margins, partnerships * **Government:** accessibility, interoperability, workforce productivity, privacy, hybrid-care targets * **Operators:** monitoring capacity, alert burden, workflows, adherence, outcomes * **Financial institutions:** contract quality, cash conversion, concentration, compliance, scalability ### What You'll Gain * Market sizing and trajectory * Reimbursement and policy mapping * Patient adoption indicators * Segment economics and levers * Competitive platform shortlist * CEO-grade risk priorities --- --- ## Research Methodology # CHAPTER 11 - Research Methodology ### Phase 1: Approach #### Desk Research * Dutch digital-care utilization trend review * Telemonitoring reimbursement code assessment * Hospital and insurer procurement mapping * Clinical pathway adoption benchmarking #### Primary Research * Hospital digital-transformation director interviews * Remote-monitoring nurse manager interviews * Health insurer procurement lead interviews * Telemedicine platform executive interviews #### Validation and Triangulation * 268 respondent evidence validation * Provider-volume and pricing reconciliation * Reimbursement and utilization cross-checks * Peer-market growth benchmarking ### Phase 2: Market Size Estimation #### Top-Down Assessment * National healthcare expenditure and digital-care intensity * Hospital, primary-care, mental-health and home-care allocation * CBS, RIVM, NZa and OECD indicators #### Bottom-Up Modeling * Provider contracts and monitored-patient benchmarks * Per-patient subscriptions and reimbursed service rates * Engagement volume multiplied by revenue intensity #### Forecasting and Scenario Analysis * Ageing, hybrid-care and provider-adoption regression * Reimbursement, interoperability and workforce scenarios * Baseline, optimistic and constrained projections through 2031 ### Phase 3: Primary Research Coverage #### Scope Item / Segments Coverage spans the full value chain of the Netherlands Telemedicine Market from technology supply and clinical delivery to reimbursement and patient use. * Hospital Virtual Care * Primary and Specialist Teleconsultation * Remote Monitoring Platforms * Insurer and Patient Adoption #### Sample Size A total of 268 respondents were engaged across four segments to ensure statistically robust coverage of the Netherlands Telemedicine Market. * Hospital Virtual Care - 72 respondents (Digital Care Director, Medical Specialist) * Primary and Specialist Teleconsultation - 68 respondents (General Practitioner, Clinical Operations Manager) * Remote Monitoring Platforms - 64 respondents (Product Director, Remote Monitoring Nurse) * Insurer and Patient Adoption - 64 respondents (Healthcare Procurement Manager, Patient Experience Lead) #### Validation and Triangulation Findings were validated across respondent cohorts and value-chain segments using consistent market definitions and reconciliation controls. * Cross-segment patient-volume consistency checks * Platform, provider and insurer revenue triangulation * Operational and strategic respondent alignment * Tariff, adoption and contract sanity checks --- --- ## Frequently Asked Questions # CHAPTER 12 - FAQs #### Q: What is the size of the Netherlands Telemedicine Market in 2025? **A:** The Netherlands Telemedicine Market was worth USD 2.5 billion in 2025. The estimate covers teleconsultation, remote patient monitoring, tele-diagnostics, digital treatment and enabling software, devices and clinical services. Growth has been supported by rising provider adoption, reimbursed telemonitoring and the shift toward hybrid care. The revenue lens excludes general consumer wellness products without a clinical-care link, keeping the scope aligned with healthcare-provider and insurer purchasing. **Data used:** USD 2.5 billion market value (2025); 80% provider video-call adoption (2025) **So what:** Investors should prioritize vendors with recurring clinical-pathway revenue rather than stand-alone video functionality. #### Q: How fast will the Netherlands Telemedicine Market grow through 2031? **A:** The market is forecast to reach USD 6.479 billion by 2031, representing a 17.2% CAGR during 2026-2031. Growth is expected to accelerate as remote monitoring, virtual wards and interoperable patient communication expand beyond pilot programs. Value growth should outpace engagement-volume growth because each monitored patient increasingly generates software, device, analytics and clinical-service revenue. Reimbursement and evidence-based procurement will determine how much of this growth translates into sustainable margins. **Data used:** USD 6.479 billion forecast value (2031); 17.2% CAGR (2026-2031) **So what:** Strategy teams should build capacity for integrated care pathways before procurement consolidates around national-scale platforms. #### Q: Where will the largest telemedicine profit pool shift occur? **A:** The largest profit-pool shift will occur from basic teleconsultation toward remote patient monitoring and disease-specific care orchestration. Video and messaging are becoming standard platform features, while monitoring supports higher-value subscriptions, device bundles, nurse review and reimbursed clinical services. Cardiology, COPD, diabetes and post-discharge pathways are especially attractive because they combine measurable outcomes with recurring engagement. Platforms that integrate alerts into EHR workflows can defend pricing better than isolated patient apps. **Data used:** EUR 194.92 telemonitoring tariff cap (2026); 3.75 million residents aged 65-plus (2025) **So what:** Operators should allocate product investment to monitored-care economics, clinical protocols and workflow integration. #### Q: What is the primary risk to market expansion? **A:** The primary risk is implementation friction rather than lack of demand. Fragmented data systems, clinician alert burden, limited workflow redesign and uneven digital literacy can prevent pilots from scaling. Older and lower-education groups use digital care materially less often, requiring assisted onboarding and non-digital alternatives. Providers also report mixed workload effects, so solutions must remove tasks rather than add parallel communication channels. Procurement will increasingly require documented productivity, safety and equity outcomes. **Data used:** 20%-45% digital-use gap for vulnerable groups (2025); 45% healthcare employees reporting excessive workload (pre-2024) **So what:** Vendors need implementation services and measurable workflow savings to protect renewals and margins. #### Q: How does the Netherlands compare with peer telemedicine markets? **A:** The Netherlands ranks fourth among the selected peer set by 2025 market size, behind Germany, the United Kingdom and France but ahead of Belgium and Denmark. Its smaller population constrains absolute scale, yet per-capita healthcare spending, national connectivity and provider adoption make it commercially attractive. Forecast growth of 17.2% is competitive with the major continental markets and stronger than smaller neighboring peers. The country can also serve as an export test bed for interoperable European care models. **Data used:** 4th peer ranking (2025); USD 8,436 health spending per capita (2024) **So what:** International suppliers can use Dutch deployments as reference accounts for broader European expansion. #### Q: Which demand driver has the strongest long-term impact? **A:** Ageing combined with chronic-care capacity pressure is the strongest long-term demand driver. The 65-plus population is projected to rise from 3.75 million in 2025 to 4.17 million by 2030, increasing demand for cardiology, respiratory, diabetes, medication and post-acute monitoring. At the same time, healthcare spending is already above 10% of GDP, forcing payers to seek productivity gains. Telemedicine adoption is therefore tied to system sustainability rather than convenience alone. **Data used:** 4.17 million residents aged 65-plus (2030); 10.2% healthcare spending share of GDP (2025) **So what:** Market entrants should focus on high-cost chronic pathways with clear avoidable-care economics. #### Q: What regulatory development matters most for telemedicine platforms? **A:** The European Health Data Space is the most consequential medium-term regulatory development because it creates a staged framework for electronic health-data exchange across the EU. Patient summaries and e-prescriptions enter the first major application phase in 2029, followed by images, laboratory results and discharge reports in 2031. Dutch platforms that invest early in structured data, consent, security and interoperability can reduce future compliance cost and strengthen cross-border scalability. **Data used:** EHDS entry into force (26 March 2025); second priority-data phase (March 2031) **So what:** Buyers should make interoperability readiness a core vendor-selection criterion today. --- --- ## Table of Contents # CHAPTER 14 - Table of Contents ### Market Report Structure Comprehensive coverage across three strategic phases: Market Assessment, Go-To-Market Strategy and Survey, delivering end-to-end insights from market analysis and execution roadmap to customer demand validation. ## Market Assessment Phase Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts. ### 1. Executive Summary and Approach ### 2. Netherlands Telemedicine Market Overview #### 2.1 Key Insights and Strategic Recommendations #### 2.2 Netherlands Telemedicine Market Overview #### 2.3 Definition and Scope #### 2.4 Evolution of Market Ecosystem #### 2.5 Timeline of Key Regulatory Milestones #### 2.6 Value Chain and Stakeholder Mapping #### 2.7 Business Cycle Analysis #### 2.8 Policy and Incentive Landscape ### 3. Netherlands Telemedicine Market Analysis #### 3.1 Growth Drivers ##### 3.1.1 Institutional Shift Toward Hybrid Care ##### 3.1.2 Ageing and Chronic-Care Capacity Pressure ##### 3.1.3 High Digital Readiness and Provider Adoption #### 3.2 Market Challenges ##### 3.2.1 Persistent Digital Inclusion Gap ##### 3.2.2 Fragmented Interoperability and Workflow Integration ##### 3.2.3 Uncertain Productivity Realization #### 3.3 Market Opportunities ##### 3.3.1 Scaled Remote Monitoring for Chronic Disease ##### 3.3.2 Interoperability-as-a-Service ##### 3.3.3 AI-Supported Clinical Triage and Automation #### 3.4 Market Trends ##### 3.4.1 Virtual Wards and Hospital-at-Home ##### 3.4.2 Disease-Specific Remote Monitoring ##### 3.4.3 AI-Enabled Alert Prioritization ##### 3.4.4 EHR-Embedded Patient Communication #### 3.5 Government Regulation ##### 3.5.1 NZa Telemonitoring Reimbursement ##### 3.5.2 European Health Data Space ##### 3.5.3 GDPR and Health-Data Security ##### 3.5.4 Medical Device Compliance ### 4. SWOT Analysis ### 5. Stakeholder Analysis ### 6. Porter's Five Forces Analysis ### 7. Netherlands Telemedicine Market Market Size, 2020-2025 #### 7.1 By Value #### 7.2 By Volume #### 7.3 By Average Selling Price ### 8. Netherlands Telemedicine Market Segmentation #### 8.1 Service Type ##### 8.1.1 Teleconsultation Services ##### 8.1.2 Remote Patient Monitoring ##### 8.1.3 Tele-diagnostics ##### 8.1.4 Digital Therapeutics and Coaching #### 8.2 Care Setting ##### 8.2.1 Hospitals and University Medical Centers ##### 8.2.2 General Practice and Primary Care ##### 8.2.3 Mental Health and Rehabilitation ##### 8.2.4 Home and Long-Term Care #### 8.3 End User ##### 8.3.1 Healthcare Providers ##### 8.3.2 Health Insurers ##### 8.3.3 Patients and Caregivers ##### 8.3.4 Employers and Public Health Bodies #### 8.4 Clinical Specialty ##### 8.4.1 Mental Health ##### 8.4.2 Cardiology and Chronic Care ##### 8.4.3 Dermatology ##### 8.4.4 Pulmonology and Diabetes #### 8.5 Delivery Channel ##### 8.5.1 Mobile Applications ##### 8.5.2 Web Portals ##### 8.5.3 Integrated EHR Platforms ##### 8.5.4 Contact Centers and Video Hubs #### 8.6 Technology ##### 8.6.1 Cloud Software ##### 8.6.2 Connected Medical Devices ##### 8.6.3 AI and Analytics ##### 8.6.4 Interoperability APIs #### 8.7 Geography ##### 8.7.1 Randstad ##### 8.7.2 North Netherlands ##### 8.7.3 East Netherlands ##### 8.7.4 South Netherlands ### 9. Netherlands Telemedicine Market Competitive Analysis #### 9.1 Market Share of Key Players (Micro, Small, Medium, Large Enterprises) #### 9.2 Cross Comparison of Key Players ##### 9.2.1 Company Name ##### 9.2.2 Group Size (Large, Medium, or Small as per industry convention) ##### 9.2.3 Monitored Patient Scale ##### 9.2.4 EHR Integration Coverage ##### 9.2.5 Recurring Revenue Growth ##### 9.2.6 Gross Margin #### 9.3 SWOT Analysis of Top Players #### 9.4 Pricing Analysis #### 9.5 Detailed Profile of Major Companies ##### 9.5.1 Philips Healthcare ##### 9.5.2 Ksyos ##### 9.5.3 Luscii ##### 9.5.4 BeterDichtbij ##### 9.5.5 Minddistrict ##### 9.5.6 Sananet ##### 9.5.7 Karify ##### 9.5.8 Medicinfo ##### 9.5.9 MiBida ##### 9.5.10 Tunstall Healthcare ### 10. Netherlands Telemedicine Market End-User Analysis #### 10.1 Procurement Behavior of Key End-Users ##### 10.1.1 Hospital Enterprise Procurement ##### 10.1.2 GP Network Contracting ##### 10.1.3 Insurer Reimbursement Decisions ##### 10.1.4 Long-Term Care Purchasing #### 10.2 Corporate Spend Patterns ##### 10.2.1 Platform Subscription Budgets ##### 10.2.2 Device and Logistics Spend ##### 10.2.3 Integration and Implementation Costs ##### 10.2.4 Clinical Monitoring Service Fees #### 10.3 Pain Point Analysis by End-User Category ##### 10.3.1 Clinician Alert Burden ##### 10.3.2 Patient Digital Exclusion ##### 10.3.3 Data Fragmentation ##### 10.3.4 Reimbursement Complexity #### 10.4 User Readiness for Adoption ##### 10.4.1 Provider Digital Maturity ##### 10.4.2 Patient Confidence ##### 10.4.3 Caregiver Enablement ##### 10.4.4 Regional Deployment Capacity #### 10.5 Post-Deployment ROI and Use Case Expansion ##### 10.5.1 Avoided Outpatient Visits ##### 10.5.2 Reduced Hospital Admissions ##### 10.5.3 Clinical Productivity Gains ##### 10.5.4 Multi-Specialty Pathway Expansion ### 11. Netherlands Telemedicine Market Future Size, 2026-2031 #### 11.1 By Value #### 11.2 By Volume #### 11.3 By Average Selling Price ## Go-To-Market Strategy Phase Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook. ### 1. Whitespace Analysis and Business Model Canvas #### 1.1 Remote Monitoring Whitespace #### 1.2 Hybrid Mental-Health Pathways #### 1.3 Interoperability Service Gaps #### 1.4 Regional Provider Opportunities ### 2. Marketing and Positioning Recommendations #### 2.1 Clinical Outcome Positioning #### 2.2 Workforce Productivity Messaging #### 2.3 Insurer Value Proposition #### 2.4 Patient Accessibility Positioning ### 3. Distribution Plan #### 3.1 Hospital Group Partnerships #### 3.2 GP Cooperative Channels #### 3.3 Insurer Contracting #### 3.4 EHR Ecosystem Partnerships ### 4. Channel and Pricing Gaps #### 4.1 Subscription Pricing Gaps #### 4.2 Per-Patient Tariff Alignment #### 4.3 Device Bundle Economics #### 4.4 Implementation Fee Structure ### 5. Unmet Demand and Latent Needs #### 5.1 Elderly-Friendly Interfaces #### 5.2 Rural Specialist Access #### 5.3 Integrated Alert Management #### 5.4 Multilingual Patient Support ### 6. Customer Relationship #### 6.1 Clinical Success Management #### 6.2 Patient Onboarding Support #### 6.3 Insurer Reporting Cadence #### 6.4 Renewal and Expansion Management ### 7. Value Proposition #### 7.1 Avoided-Care Economics #### 7.2 Faster Specialist Access #### 7.3 Scalable Monitoring Capacity #### 7.4 Compliant Data Exchange ### 8. Key Activities #### 8.1 Clinical Pathway Design #### 8.2 EHR Integration #### 8.3 Outcome Measurement #### 8.4 Reimbursement Enablement ### 9. Entry Strategy Evaluation #### 9.1 Domestic Market Entry Strategy ##### 9.1.1 Select Clinical Beachhead ##### 9.1.2 Secure Hospital Reference Site ##### 9.1.3 Establish Insurer Evidence Case ##### 9.1.4 Expand Through GP Networks #### 9.2 Export Entry Strategy ##### 9.2.1 Benelux Expansion ##### 9.2.2 Nordic Partnership Model ##### 9.2.3 German Reimbursement Alignment ##### 9.2.4 United Kingdom Provider Partnerships ### 10. Entry Mode Assessment #### 10.1 Direct Enterprise Sales #### 10.2 Local Clinical Partnership #### 10.3 EHR Marketplace Distribution #### 10.4 Acquisition or Joint Venture ### 11. Capital and Timeline Estimation #### 11.1 Product Localization Capital #### 11.2 Regulatory and Security Investment #### 11.3 Integration Team Build-Out #### 11.4 Commercial Scale Timeline ### 12. Control vs Risk Trade-Off #### 12.1 Clinical Control #### 12.2 Data Governance Risk #### 12.3 Partner Dependence #### 12.4 Reimbursement Exposure ### 13. Profitability Outlook #### 13.1 Gross Margin by Service #### 13.2 Patient Acquisition Economics #### 13.3 Implementation Cost Recovery #### 13.4 Renewal-Led EBITDA Expansion ### 14. Potential Partner List #### 14.1 Hospital Groups #### 14.2 GP Cooperatives #### 14.3 Health Insurers #### 14.4 EHR and Device Vendors ### 15. Execution Roadmap #### 15.1 Phased Plan for Market Entry ##### 15.1.1 Market Setup ##### 15.1.2 Market Entry ##### 15.1.3 Growth Acceleration ##### 15.1.4 Scale and Stabilize #### 15.2 Key Activities and Milestones ##### 15.2.1 Regulatory Readiness ##### 15.2.2 Reference Deployment ##### 15.2.3 Insurer Contracting ##### 15.2.4 National Expansion ## Survey Phase Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers. ### 1. Research Design and Sample Architecture #### 1.1 Research Objectives and Scope #### 1.2 Sample Size Rationale and Representation #### 1.3 Customer Cohort Definitions #### 1.4 Geographic Coverage: Priority Metros and Regional Cities ### 2. Data Collection Methodology #### 2.1 Structured Interview Framework (50 In-Depth Interviews) ##### 2.1.1 Interview Guide and Question Design ##### 2.1.2 Respondent Recruitment and Screening Criteria ##### 2.1.3 Interview Execution and Quality Control ##### 2.1.4 Qualitative Coding and Insight Extraction #### 2.2 Online Survey Design (200 Structured Surveys) ##### 2.2.1 Survey Instrument and Attribute Coverage ##### 2.2.2 Platform Selection and Distribution Channels ##### 2.2.3 Response Validation and Data Cleaning ##### 2.2.4 Statistical Significance and Margin of Error ### 3. Customer Cohort Profiles #### 3.1 Cohort 1: Hospital and University Medical Center Users ##### 3.1.1 Cohort Definition and Size ##### 3.1.2 Key Demand Attributes ##### 3.1.3 Purchase Decision Drivers ##### 3.1.4 Represented Sample Size and Metro Distribution #### 3.2 Cohort 2: GP and Community Care Users ##### 3.2.1 Cohort Definition and Size ##### 3.2.2 Key Demand Attributes ##### 3.2.3 Purchase Decision Drivers ##### 3.2.4 Represented Sample Size and City Distribution #### 3.3 Cohort 3: Remote Monitoring Patients ##### 3.3.1 Cohort Definition and Size ##### 3.3.2 Key Demand Attributes ##### 3.3.3 Purchase Decision Drivers ##### 3.3.4 Represented Sample Size and Regional Distribution #### 3.4 Cohort 4: Insurer and Public-Sector Buyers ##### 3.4.1 Cohort Definition and Size ##### 3.4.2 Key Demand Attributes ##### 3.4.3 Procurement and Compliance Drivers ##### 3.4.4 Represented Sample Size and Regional Distribution ### 4. Demand Attributes Analysis #### 4.1 Macroeconomic and Sectoral Growth Influences on Demand ##### 4.1.1 Healthcare Expenditure Linkages ##### 4.1.2 Ageing and Chronic-Care Impact ##### 4.1.3 Hospital Investment Cycles ##### 4.1.4 European Technology Dependency #### 4.2 End-User Behavior and Consumption Patterns ##### 4.2.1 Frequency and Volume of Digital Contacts ##### 4.2.2 Condition-Specific Monitoring Patterns ##### 4.2.3 Platform Loyalty vs. Workflow Fit ##### 4.2.4 Switching Triggers and Retention Factors #### 4.3 Pricing Perception and Value Assessment ##### 4.3.1 Willingness to Pay Across Buyers ##### 4.3.2 Pricing Against In-Person Care ##### 4.3.3 Regional Contracting Differences ##### 4.3.4 Total Cost of Ownership Perception #### 4.4 Quality, Safety, and Compliance Expectations ##### 4.4.1 Clinical Evidence Requirements ##### 4.4.2 Privacy and Security Awareness ##### 4.4.3 Domestic vs. International Platform Perception ##### 4.4.4 Support and Service Expectations #### 4.5 Cultural, Regional, and Contextual Demand Factors ##### 4.5.1 Randstad Innovation Clusters ##### 4.5.2 Primary-Care Gatekeeping Norms ##### 4.5.3 Professional Association Influence ##### 4.5.4 Digital Adoption and Patient Readiness #### 4.6 Marketing, Awareness, and Channel Influence ##### 4.6.1 Clinical Conference Influence ##### 4.6.2 Digital Thought Leadership ##### 4.6.3 Insurer and Provider Network Influence ##### 4.6.4 EHR and Device Partnership Impact ### 5. Unmet Needs and Latent Demand Signals #### 5.1 Gaps Between Current Supply and Clinical Workflows #### 5.2 Latent Demand in Underpenetrated Care Settings #### 5.3 Willingness to Adopt AI and Monitoring #### 5.4 Pain Points Surfaced Across Cohorts ### 6. Key Findings and Strategic Implications #### 6.1 Top Demand Drivers Ranked by Cohort #### 6.2 Barriers to Purchase and Adoption #### 6.3 High-Priority Customer Segments for Market Entry #### 6.4 Recommendations for Product, Pricing, and Channel Strategy ### Disclaimer ### Contact Us